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Peptidoglycan (PG)-polysaccharide (PS) polymers derived from group A strep-
tococcal cell walls were solubilized by M-1 mutanolysin (endo-N-acetylmurami-
dase) and phage-associated lysin (N-acetylmuramyl-L-alanine amidase). Frag-
ments were isolated by ultrafiltration and a series of gel filtrations and were
injected intravenously into Sprague-Dawley rats. No fragments with a molecular
weight of less than 5 x 106 were able to induce arthritis by systemic injection.
However, the enzyme-derived fragments displayed a new biological activity.
High-molecular-weight PG-PS fragments (-500,000) derived from mutanolysin
digests induced a severe edematous reaction in the front and hind limbs. The
response started 5 to 10 min postinjection, reached maximum intensity in
approximately 30 min, and disappeared by 10 h. The smallest dose capable of
eliciting the response was 0.31 ,ug/g of body weight. Low-molecular-weight PG-PS
(-30,000) derived from the mutanolysin digests and the PG-PS fragments isolated
from phage-associated lysin digests also induced edema; however, a higher dose
was required to elicit the same response as that produced by high-molecular-
weight PG-PS fragments. The active fragments contained rhamnose, glucosamine,
muramic acid, alanine, glutamic acid, and lysine in various molar ratios. PG-PS
fragments obtained by sonic degradation of cell walls (molecular weight ¢5.3 x
106), as well as enzyme-treated PG preparations and muramyl dipeptide, failed to
elicit the response. These findings indicate that PG-PS fragments of sizes too
small to be arthritogenic can affect the vascular endothelium to induce a rapidly
developing edema. Fragments with this biological property could have a key role
in the pathogenesis of experimental arthritis by influencing the tissue distribution
of arthritogenic PG-PS.
A single injection of an aqueous suspension of
group A streptococcal cell wall produces chron-
ic, remittent inflammation in joints, heart, intes-
tines, or skin; the location of lesions depends on
the species of animal and the route of injection
(4, 5, 20, 21, 24, 25). In each of the experimental
models, the essential cell wall structure is the
peptidoglycan (PG)-polysaccharide (PS) com-
plex. The arthritis produced in rats by intraperi-
toneal injection of PG-PS is clinically, histologi-
cally, and radiologically similar to human
rheumatoid arthritis (3, 5). Recently, we report-
ed that the size of PG-PS fragments obtained by
sonic degradation of cell wall plays an important
role in determining the relative severity of the
early and late phases of arthritis in the rat model
(10). The smallest fragments (molecular weight
[MW], 5.3 x 106) induced the most severe early
inflammation of joints with relatively little
chronic joint disease, whereas the intermediate-
size fragments (MW, 5.0 x 107) induced moder-
ate early inflammation and the most severe
chronic, erosive joint lesions (10).
The finding that the size of PG-PS fragments
plays an important role in the arthropathogenici-
ty of the cell wall prompted us to utilize cell
wall-lytic enzymes to generate a greater spec-
trum of size and structural modification of the
PG-PS fragments to relate more precisely bio-
logical activity and structure. The cell wall-lytic
enzymes utilized in these studies included mu-
tanolysin (27, 28) and group C streptococcal
phage-associated lysin (8, 9, 15). This report
describes methods of isolation and characteriza-
tion of the PG-PS fragments generated by these
enzymes and the biological properties of these
fragments.
MATERIALS AND METHODS
Preparation of cell wall. Purified cell walls were
prepared from group A, type 3, strain D58 streptococci
as previously described (10). In brief, the cells were
grown in Todd-Hewitt broth, harvested, and washed
in a sterile phosphate-buffered saline (PBS) (0.04 M
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phosphate, 0.15 M NaCI [pH 7.2]). Washed cells were
disrupted in a Braun MSK shaker, and the cell walls
were collected by differential centrifugation (10,000 x
g for 30 min at 4°C) and further purified by sequential
RNase, trypsin, and papain treatments and by chloro-
form-methanol extraction. The purified cell walls,
which consisted primarily of PG-PS complexes, were
extracted with formamide (16) to obtain PG prepara-
tions. In addition, PG preparations were prepared
from streptococcal group A-variant strain K43.
Cell wall-lytic enzymes. The M-1 fraction of mutano-
lysin (an endo-N-acetylmuramidase) was obtained
from K. Yokogawa (Dianippon Pharmaceuticals, Ltd.,
Osaka, Japan). Before use, the enzyme was suspended
in acetate buffer containing Mg2" and NaN3 (0.05 M
sodium acetate, 0.5 mM MgSO4, 0.05% NaN3 [pH
5.5]) at 1 mg/ml and sonicated for 20 s at a setting of 8
with a sonifier (model 350; Branson Sonic Power Co.,
Danbury, Conn.) equipped with a cup horn (Heat
Systems, Ultrasonics, Inc., Plainview, N.Y.).
Group C streptococcal phage-associated lysin was
purified according to the method of Fischetti et al. (8);
however, the purification process was carried out only
to the second step (cellulose phosphate chromatogra-
phy). The partially purified enzyme was stored at
-80°C in phosphate buffer (0.1 M K2HP04 [pH 6.1])
containing 0.4 M NaCI, 0.005 M EDTA, and 10%o
glycerol. The enzyme was activated by preparing an
initial 1:10 dilution of the stock in 5 x 10-2 M
dithiothreitol and allowing it to stand at room tempera-
ture for 15 min before use (8).
Animals. Outbred female Sprague-Dawley rats that
weighed 120 to 160 g at the beginning of the experi-
ments were obtained from Zivic-Miller, Allison Park,
Pa.
Muramyl dipeptide. Muramyl dipeptide (MDP; N-
acetylmuramyl-L-alanyl-D-isoglutamine) was obtained
from Sigma Chemical Co., St. Louis, Mo. or from
Ciba-Geigy Ltd., Basle, Switzerland (gift of E. D.
Wachsmuth). Samples were dissolved in sterile PBS
before use, and the pH was adjusted to 7.4 with 1 N
NaOH.
lodination of human serum albumin. Human serum
albumin (HSA) (Cutter Laboratories, Berkeley, Calif.)
was iodinated with '251 (Amersham Corp., Oakville,
Ontario, Canada) by bovine lactoperoxidase, which
was covalently coupled to Sepharose 4B as described
by David and Reisfeld (6). The [125I]HSA had a
specific activity of 46.17 ,uCi/mg of HSA and was
diluted with PBS before use.
Method of scoring acute nflammation. Rats in
groups offour or five were injected intravenously (i.v.)
with 0.2 to 0.4 ml of the fractions or preparations to be
tested. In all of the experiments, the fractions or
preparations were dissolved in and diluted with sterile
PBS. Negative control groups were injected with PBS,
and the endotoxin control groups were injected with
solutions of Salmonella typhimurium lipopolysaccha-
ride (Difco Laboratories, Detroit, Mich.). A positive
response was indicated by the appearance of edema in
the front and hind limbs within 30 min postinjection.
The intensity of edema of each limb was estimated by
using an arbitrary 0 to 4 scale; therefore, the maximum
total score that a rat could receive was 16.
The accuracy and precision of scoring was deter-
mined by comparing the clinical assessment of swell-
ing with the amount of ['25 ]HSA accumulation in the
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FIG. 1. Scheme for the isolation of PG-PS frag-
ments from group A streptococcal cell wall. F, Frag-
ment; VO, void volume.
limbs. For these measurements, edema was induced
locally in the limbs by injecting edema-producing PG-
PS fragments through the Achilles tendon into the
region of the tibio-talor joint. Quantitation of
['25I]HSA accumulation in the limbs was performed by
injecting a group of four rats i.v. with [1251]HSA (1.15
X 10-3 RCi/g of body weight); 30 min later, the rats
were injected in the left joint with 10 ,ul of PBS and in
the right joint with 10 R1 of a PG-PS peparation. Thirty
minutes after intraarticular injection, the rats were
scored for edema and immediately anesthesized with
ether, the heart blood was collected, and the left and
the right limbs were removed. The amount of
['25 ]HSA in the left and right limbs and in the blood
was determined with a gamma counter (1197 series
Automatic Gamma Counting System; Searle Analytic
Inc., Des Plaines, 11.).
Preparation of active cell wall fragments (PG-PS) by
enzyme treatments. Purified cell wall (500 mg) was
suspended to a concentration of 1 mg/ml in acetate
buffer (0.05 M sodium acetate [pH 5.5]) containing 0.5
mM MgCI2 and 0.05% NaN3. Mutanolysin (5.0 mg in 5
ml of acetate buffer) was added to the cell wall
suspension, and the mixture was incubated, with peri-
odic mixing, at 37°C for% h. Samples were taken from
the incubation mixture at various times for optical
density measurements (A = 600 nm) and for reducing
sugar determinations (26). At the end of the incubation
period, the mixture was centrifuged at 10,000 x g at
4°C for 30 min to remove residual unsolubilized cell
walls. Cell wall fragments in the supernatant were
resolved into two major groups, high-molecular-
weight (HMW) PG-PS fragments and low-molecular-
weight (LMW) PG-PS fragments, by filtration through
a PM 10 membrane (Amicon Corp., Lexington, Mass.)
(Fig. 1).
The HMW PG-PS fragments (PM 10 retentate) were
dialyzed against distilled water to remove salts and
NaN3 and lyophilized. The lyophilized preparation
was dissolved in 10 ml of 0.01 M Tris-hydrochloride
buffer (pH 7.4) and applied to a 2.6- by 95-cm column
of Sepharose 6B equilibrated at 4°C with Tris-hydro-
chloride buffer and eluted at a flow rate of 18 ml/h.
Fractions of 4.5 ml were collected and assayed for
absorbance at 220 nm (A220) and for rhamnose (7). The
fractions which contained A220-absorbing materials or
rhamnose or both were tested for edema-producing
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*/ . eluted at a flow rate of 20 ml/h. Fractions of 5 ml were
collected and assayed for A220, rhamnose, and edema-
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Edema-producing PG-PS fragments were also ob-
/s.tained by treatment of the purified cell wall with group
C streptococcal phage-associated lysin. Purified cell
r=0.97 wall (500 mg) was added to 300 ml of the activated
P < 0.001 lysin and incubated at 37°C for 24 h. The cell wall-lysin
mixture was centrifuged at 10,000 x g at 4°C for 30 min
to remove insoluble materials. Solubilized cell wall
fragments in the supernatant were concentrated to 25
' ' ' ' ' ml by ultrafiltration in a stirred cell equipped with a
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FIG. 3. Edematous response in rats 30 min after i.v. injection of the mutanolysin-derived HMW PG-PS
fragments (2.5 ,ug/g of body weight). (A) Control front limb. (B) Front limb with a score of 4. (C) Control hind
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FIG. 4. Time course of edema induced by i.v. injection of mutanolysin-derived HMW PG-PS fragments at 2.5
(0), 1.2 (0), and 0.31 (A) ,ug/g of body weight. Each time point represents the average of five rats, except for the
group injected with 0.31 Fg/g of body weight, in which only one of five rats responded.
Preparation of PG-PS fragments by sonic treatment.
Lyophilized purified cell walls were sonicated for 70
min in a Branson sonifier, and the 100S60 and the
100P60 fractions were isolated from the cell wall
sonicates as previously described (10). The PG-PS
fragments in the 100S60 fraction were applied to the
previously mentioned column of Sepharose 6B and
eluted with Tris-hydrochloride buffer. The fragments
eluted in the void volume fractions of the column were
pooled, dialyzed against deionized distilled water, and
lyophilized. The MW of these fragments was approxi-
mately 5.3 x 106 (10).
Chemical analyses. Muramic acid, glucosamine, and
glucose were assayed as their alditol acetates by gas-
liquid chromatography (23). The PG-PS fragments
were hydrolyzed under vacuum for 3 h, and the PG
fragments were hydrolyzed for 2 h 15 min at 100°C
with 2 N sulfuric acid before the derivatization proc-
ess. Amino acid analyses were performed after the
samples were hydrolyzed in 6 N HCI at 110°C in vacuo
for 24 h. Hydrolyzed samples were lyophilized to
dryness, redissolved in 0.2 M sodium citrate buffer
(pH 2.2), and centrifuged to remove carmalyzed mate-
rial, and the supernatant was applied to a gradient
high-pressure liquid chromatograph adapted to per-
form postcolumn derivitization amino acid analysis as
described in detail elsewhere (D. G. Klapper, Proc.
4th Int. Conf. Methods in Protein Sequence Analysis,
in press).
Rhamnose was assayed according to the method of
Dische and Shettles (7). Reducing sugars were assayed
by the method of Thompson and Shockman (26).
MW determinations. Two methods were used to
estimate the MW of PG-PS fragments: gel filtration
and light scattering. When gel filtration was used to
estimate MW, Sephadex columns were calibrated with
dextran T fractions of known MW (Pharmacia Fine
Chemicals, Inc., Piscataway, N.J.). The Kay of each
dextran T fraction was obtained and used to correlate
with the MW, and the correlation plot was used to
obtain the MW of PG-PS fragments. MWs were deter-
mined by light scattering measurements according to
the method described by Carr et al. (1) with a refrac-
tive index increment (dnldc) of 0.160. Samples for light
scattering analysis were centrifuged (30,000 x g at 4°C
for 20 min) to remove small aggregates before use.
RESULTS
Acute inflammation induced by PG-PS frag-
ments. Preliminary experiments (Fig. 2) indicat-
ed an excellent correlation between clinical
scoring of edematous swelling and [125I]HSA
accumulation in the limbs (r = 0.97; P < 0.001).
Therefore, the clinical assessment of swelling
was used in the present studies. Within 5 to 10
min after i.v. injection of PG-PS fragments,
erythema appeared in both front and hind limbs,
followed by edematous swelling (Fig. 3). De-
pending on the dose injected, the edematous
response of the limbs usually was maximum by
30 min postinjection, began to disappear by 1 h,
and was undetectable by 10 h (Fig. 4). The time
course of edema induced by other PG-PS frag-
ments was similar to that of HMW PG-PS.
Occasionally, swelling also appeared around the
nose but not in the ears or tail. None of the
enzyme-derived PG-PS fragments was capable
of inducing chronic erosive arthritis, even when
injected at 26 jxg/g of body weight; however, at
this dose, the mutanolysin-derived HMW PG-PS
and the phage-associated lysin-derived PG-PS
induced cyanosis within 2 min. This cyanosis
lasted for approximately 15 min and was fol-
lowed by the appearance of erythema and ede-
ma, which persisted for 12 h in all extremities.
Occasionally, with this high dose, one or two of
five rats died within 30 min. Table 1 summarizes
results with various preparations.
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TABLE 1. Response of rats after i.v. injection of various cell wall and PG fragments
Dose injected No. of rats Average score of positivePrepn (p.g/g of positive/no. rt30mnpsijcoa
body wt) injected rats 30 mi postinJectiona
Fragments generated by mutanolysin
HMW PG-PS (MW _ 500,000)
LMW PG-PS (MW _ 30,000)
Fragments generated by group C streptococcal
phage-associated lysin
PG fragments derived from:
Group A strain D58 (MW _ 33,000)b
Group A-variant strain K43C
PG-PS fragments obtained by sonic treatment
100S60 (MW = 5.3 x 106)
100P60 (MW = 5.0 x 107)
MDP
Mutanolysind





















































a A positive response was indicated by the appearance of edema in the front and hind limbs. A scale of 0 to 4
was used to estimate the intensity of edema of each limb; therefore, the maximum total score per rat was 16
(mean ± 1 standard deviation).
b This PG preparation contained 4.0% (wt/wt) rhamnose, indicating the presence of a small amount of
covalently bound polysaccharide.
c Rhamnose was not detectable in this PG preparation.
d The amounts used reflected the concentration of these enzymes in the incubation mixtures.
Isolation and characterization of edema-pro-
ducing PG-PS fragments. Treatment of the puri-
fied cell walls with mutanolysin resulted in a
decrease in optical density and an increase in
reducing groups in the supernatant fluid. After
96 h, the resulting PG-PS fragments were very
heterogeneous in size. The fragments were re-
solved by ultrafiltration into two major groups,
the HMW PG-PS and the LMW PG-PS. The
yield of the HMW PG-PS was approximately
15% of the starting cell walls and was much
higher than the yield of the LMW PG-PS (1.5%).
Both PG-PS preparations induced the edema-
tous response in rats (Table 1).
The elution profile of the Sepharose 6B gel
filtration of the PM 10 retentate of the cell wall
digests showed that the HMW PG-PS fragments
were eluted in the major peak, which had a Kay
of 0.38 (Fig. 5). The weight average MW of the
fragments in this peak was approximately
500,000, as determined by light scattering. The
minimum amount of these PG-PS fragments
capable of inducing edema was approximately
0.31 ,ug/g of body weight (Table 1). The small
peak of PG-PS fragments which was eluted in
the void volume did not contain detectable ede-
ma-producing activity when a dose of 3.3 ,ug/g of
body weight was tested.
The elution profile of the Sephadex G-100 gel
filtration of the PM 10 filtrate of the cell wall
digests is shown in Fig. 6. The LMW PG-PS
fragments were eluted in the rhamnose-contain-
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FIG. 5. Sepharose 6B gel filtration of the PG-PS fragments in a PM 10 retentate derived from the treatment of
cell wall with mutanolysin. A sample (20 mg in 4.0 ml of Tris-hydrochloride) was applied to a column of
Sepharose 6B (2.6 by 95 cm) and eluted with Tris-hydrochloride at 4°C at a flow rate of 18 ml/h. Fractions (4.5 ml)
were assayed for absorbance at 220 nm (0) and for rhamnose (0). The active fractions are indicated. M w, Weight
average molecular weight; VO, void volume; Vt, total bed volume.
ing peak, which had a Kay of 0.24. The MW of
the PG-PS fragments in this peak was approxi-
mately 30,000 when determined by gel filtration
with different dextran T samples of known MW
as markers. The minimum amount of the LMW














approximately 0.7 ,ug/g of body weight (Table 1).
The materials in the second peak (Ka, = 0.81)
did not contain detectable rhamnose and did not
induce edema when tested at 10.4 ,ug/g of body
weight.
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FIG. 6. Sephadex G-100 gel filtration of the PG-PS fragments in a PM 10 filtrate which was derived from a
mutanolysin digest. A sample (25 mg in 5.0 ml of Tris-hydrochloride) was applied to a column of Sephadex G-100
(2.6 by 92.5 cm) and eluted with Tris-hydrochloride buffer (at 4°C) at a flow rate of 21 ml/h. Fractions (5 ml) were
assayed for absorbance at 220 nm (0) and for rhamnose (0). The active fractions are indicated. VO, Void volume;











.- -4Ndb.-.-% ,% 0%
1015VOL. 38, 1982
U.UU
100 140 180 220 260 300 340 380 420 460
R































FIG. 7. Elution profile of a Sepharose 6B gel filtration of PG-PS fragments generated by group C
streptococcal phage-associated lysin. A sample (5 mg in 4 ml of Tris-hydrochloride) was applied to the Sepharose
column (4°C) and eluted as described in the legend to Fig. 5. 0, Absorbance at 220 nm; *, rhamnose. The active
fractions are indicated. VO, Void volume; Vt, total bed volume.
streptococcal phage-associated lysin also yield-
ed PG-PS fragments which were capable of
inducing edema. The elution profile of the Seph-
arose 6B gel filtration of the cell wall digests
indicated that the active PG-PS fragments were
eluted in the major peak, which had a Kay of 0.44
(Fig. 7). Based on this Ka, value, the average
size of the PG-PS fragments should be similar to
or slightly smaller than the HMW PG-PS frag-
ments derived from the treatment of cell walls
with mutanolysin. In addition, the time course of
edema induced by these PG-PS fragments was
similar to that of the mutanolysin-derived HMW
PG-PS. The smallest amount of these fragments
capable of inducing edema was approximately
1.25 p.g/g of body weight (Table 1), and the yield
of the fragments was approximately 12% of the
starting cell wall preparation.
Isolation of PG fragments. The PG prepared
from group A, strain D58 streptococcal cell
walls still contained approximately 4.7% rham-
nose, even after six successive extractions with
formamide, whereas the PG preparation pre-
pared from the group A-variant strain K43 strep-
tococcal cell walls contained less than 1% rham-
nose after a similar treatment with formamide.
Both PG preparations were highly susceptible to
mutanolysin, and a complete clearing of the
incubation mixture occurred within 60 min (de-
termined by optical density at 254 nm). The
elution profiles of Sephadex G-25 gel filtration of
the group A D58 PG lysates (Fig. 8A) and the
group A-variant strain K43 PG lysates (Fig. 8B)
indicated that the majority of PG fragments were
excluded by the gel. The materials in the exclud-
ed peak derived from group A D58 PG contained
significant amounts of rhamnose. This finding
suggested the presence of PG-PS fragments.
Analysis of these PG-PS fragments by gel filtra-
tion indicated that they had sizes similar to those
of mutanolysin-derived LMW PG-PS fragments
(data not shown). On the other hand, the PG
fragments derived from K43 PG did not contain
detectable amounts of rhamnose. Thus, only
rhamnose-containing fractions of PG induced an
edematous response, and a higher dose of such
fractions was required to elicit responses com-
parable to those seen with other PG-PS frag-
ments (Table 1).
Chemical analyses. The similarities in the mo-
lar ratios of muramic acid, alanine, and glutamic
acid to lysine in the active edema-producing PG-
PS fragments (Table 2) suggested that the frag-
ments contained similar PG components. On the
other hand, the amounts of covalently bound PS
were different, as indicated by the differences in
the molar ratios of rhamnose and glucosamine to
lysine. The edema-producing PG-PS fragments
were free of other sugars and amino sugars and
contained less than 1.0% (wt/wt) non-PG-associ-
ated amino acids.
DISCUSSION
PG-PS fragments which induce acute edema
in rats were isolated from group A streptococcal
INFECT. IMMUN.
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FIG. 8. Sephadex G-25 elution profiles of mutanolysin-treated peptidoglycan fragments from (A) group A
strain D58 and (B) group A-variant strain K43 streptococci. 0, Absorbance at 254 nm; *, rhamnose. Active
fractions are indicated.
cell walls. These fragments were obtained by
treatment of cell walls with mutanolysin or
group C streptococcal phage-associated lysin
and were resolved from the cell wall digest into
two groups based on their sizes. One group
(present in large quantities) is composed of
HMW fragments (ca. 500,000), and the other
group (present in small quantities) is composed
of LMW fragments (ca. 30,000). A single i.v.
injection of an aqueous suspension of these PG-
PS fragments induced acute edema in the limbs
of rats but failed to induce arthritis. To date, the
smallest PG-PS fragments capable of inducing
arthritis in rats by a single i.v. or intraperitoneal
injection have an MW of approximately 5.3 x
106 (10); however, these PG-PS fragments fail to
induce acute edema (Table 1).
Recently, Zidek et al. (29) reported that a
solution of MDP in saline was capable of induc-
ing arthritis in rats; however, their observations
cannot be compared with our findings because
the induction of arthritis by MDP in saline was
achieved by repeated subcutaneous administra-
tion rather than by a single intraperitoneal or i.v.
injection. Furthermore, there was no evidence
of progressive, erosive, chronic arthritis in their
rats, and the effects were reversible when injec-
tions of MDP were stopped. It is also difficult to
compare our findings with the adjuvant arthritis
induced by MDP (2, 14, 17) because an oil
vehicle is essential in that model, and again,
there is no published evidence of a chronic,
erosive disease.
Other studies relating the size and fine struc-
ture of the streptococcal group A cell wall to its
biological activities include the findings that the
PG-PS fragments obtained from the treatment of
group A streptococcal cell wall with L-11 en-
zyme (Kyowa lytic no. 2) (12) possessed pyro-
genic activity in rabbits (13) and that the frag-
ments induced cardiac lesions in mice (18).
However, it is not known whether the products
of the L-11 enzyme (in aqueous suspension) are
capable of inducing arthritis (5) or edema as
described in this report. Cell walls isolated from
several bacterial species, including Streptococ-
cus pyogenes, as well as MDP and some of the 6-
O-acyl derivatives of MDP, induced contraction
of guinea pig ileal strips (19). In addition, Ohkuni
and Kimura (22) have shown that the PG frac-
tion extracted from group A streptococcal cell
walls can cause increased capillary permeability
of the skin of guinea pigs and rats when it is
injected intracutaneously. Their results cannot
be directly compared with ours because of the
differences in the routes of injection.
The results of chemical analyses of various
edema-producing PG-PS fragments (Table 2) in-
dicated that all fragments contained similar PG
components. However, the mutanolysin-derived
HMW PG-PS and the phage-associated lysin-
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TABLE 2. Chemical analyses of PG-PS fragments which induced edema in rats
Fragments generated by mutanolysin Fragments generated by Fragments obtained from
Component"HMW LMW phage-associated lysin group A strain D58 PGComponent' HMW_________ ________LMW_ prepns
%WtW)Molar ratio %(tt)Molar ratio %(tw Molar ratio %wtt)Molar ratio% (wtwt) olyrat (wt/wt) M°iy at° (wtlwt) Molysiane (wt/wt) tolysineto lysine to lysine tolyieto lsn
Rhamnose 33.0 19.1 13.8 4.3 25.0 15.5 4.0 1.1
Glucosamine 22.3 11.7 12.0 3.5 12.5 7.1 8.7 2.1
Muramic acid 3.1 1.2 3.1 0.6 1.5 0.6 6.5 1.1
Alanine 2.7 2.8 8.2 4.7 2.4 2.7 6.5 3.2
Glutamic acid 1.8 1.1 3.7 1.3 1.6 1.1 3.7 1.1
Lysine 1.6 1.0 2.8 1.0 1.4 1.0 3.3 1.0
a Other amino acids were present in less than 1% (wt/wt). Other sugars and amino sugars were not detected.
mers of the covalently bound PS than did LMW
PG-PS. The differences in the molar ratios of
rhamnose and glucosamine to lysine in these
PG-PS fragments suggest heterogeneity of the
length of PS polymers. Recently, the heteroge-
neity of the group A streptococcal PS was
demonstrated by immunochemical analysis (11),
and the authors suggested that the heterogeneity
may have resulted from attachment of various
amounts of N-acetylglucosamine to the poly-
rhamnose backbone. Under the conditions used
in the present studies, we observed that the
mutanolysin-derived LMW PG-PS and the PG-
PS fragments obtained from the formamide-
extracted cell walls were less active in eliciting
the edematous response than were those of the
mutanolysin-derived HMW PG-PS (Table 1). It
is not known whether this resulted from the
differences in their sizes or from the differences
in the length of the covalently bound rhamnose
oligosaccharides.
Experiments are in progress in our laboratory
to determine the active moiety of the edema-
producing PG-PS fragments. The findings that
all of the active fragments contained a PS moiety
and that the severity of edema was related to the
size of the PS polymers suggest that PS is the
active moiety. Furthermore, the absence of ede-
ma-producing activity in the PG fragments
which were derived from the group A-variant
(K43) PG preparation and which did not contain
detectable amounts of rhamnose supports the
idea that PS is essential for the activity. If so,
this is the first documented report of biological
activity of a group-specific polysaccharide.
Our working hypothesis is that this early
edematous response reflects an effect of soluble
PG-PS fragments on vascular endothelium of the
synovial tissue. This might be important as an
initial step in the pathogenesis of experimental
arthritis induced by systemic injection of strep-
tococcal cell walls. The edema-producing PG-PS
fragments are present in small concentrations in
the cell wall sonicate which is used to induce the
experimental arthritis (data not shown). In addi-
tion, it is possible that edema-producing PG-PS
fragments could be generated from the larger-
size cell walls through an in vivo degradation
process. In any case, the edema-producing PG-
PS fragments cause an initial increase in vascu-
lar permeability which may facilitate localization
of the larger arthritogenic fragments in the joint.
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